Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q3 2022 Earnings Presentation
11 slides from Phibro Animal Health's earnings presentation, May 5, 2022
Slide 1: Phibro Animal Health Corporation Webcast and Conference Call
Phibro Animal Health Corporation Webcast and Conference Call May 5, 2022 Financial Results U.S. toll-free +1.888.330.2022 Fiscal Year 2022 International toll +1.365.977.0051 Third Quarter Ended March 31, 2022 Conference ID: [3927884] May 5, 2022
Slide 2: Important Information
Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to future debt and leverage levels. All statements other than statements of historical or current
Slide 3: Key Themes
Key Themes Third Quarter Raised Net Sales Fiscal year-to-date Net Aggressive price Macroeconomic guidance, Sales growth across all increases taken to headwinds persist maintained Adjusted segments and regions combat inflation EBITDA guidance Year-to-date Net Sales The Russian / Ukraine Price increas
Slide 4: Financial Performance - Consolidated
Financial Performance - Consolidated Third Quarter, Year-on-Year comparison $ in millions, except per share data Net Sales – increased $27.9 million, or 13%, increase driven YOY by improvement across all reportable business segments, Q3 %∆ major product categories and geographic regions Net Inco
Slide 5: Financial Performance – Animal Health
Financial Performance – Animal Health Third Quarter, Year-on-Year comparison $ in millions Net Sales – increased $14.2 million, or 11% YOY MFAs and other Q3 %∆ - Increased $5.8 million, or 7%, driven by increased Animal Health sales of processing aids used to improve production efficiency in the
Slide 6: Financial Performance – Other Segments
Financial Performance – Other Segments Third Quarter, Year-on-Year comparison $ in millions YOY Mineral Nutrition Q3 %∆ - Net Sales increased $10.9 million, or 19%, primarily driven by higher average selling prices of trace minerals correlated with Mineral Nutrition the movement of the underlying
Slide 7: Key Capitalization Metrics
Key Capitalization Metrics Third Quarter Highlights $1 million of trailing 12-month free cash flow; operating cash Free Cash Flow flow of $33 million less capital expenditures of $32 million 3.9x gross leverage ratio; $417 million total debt / Leverage $107 million trailing 12-month adjusted EBITDA
Slide 8: Revised Financial Guidance
Revised Financial Guidance Fiscal Year 2022 $ in millions, except per share data FULL YEAR Current Guidance Revised Guidance Given our year-to-date financial performance, Low High Low High we raised financial guidance for Net Sales with no change to Adjusted EBITDA guidance due to Net Sales $ 890.
Slide 9: Inaugural ESG Report
Inaugural ESG Report We plan to publish our inaugural Environmental, Social & Governance (ESG) Report shortly. 9 May 5, 2022
Slide 10: Q&A
Phibro 10 May 5, 2022 HEALTHY ANIMALS, HEALTHY FOOD. HEALTHY WORLD. * uc net CORPORAT CN
Slide 11: © 2022 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy
© 2022 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that